Mast Cell Activation Syndrome Treatment Conventional treatment for mast cell activation syndrome generally involves the use of pharmaceutical and over-the-counter medications to alleviate symptoms, such as the following medications: Epinephrine (such as an EpiPen) for severe reactions First generation H1 blockers diphenhydramine (Benadryl) and hydroxyzine (Vistaril) Second generation H1 blockers, including loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) H2 blockers, such as ranitidine (Zantac) and famotidine (Pepcid) Aspirin, to block production of prostaglandin D2 and reduce flushing
When combined with proper medical oversight and lifestyle strategy, they can help patients achieve meaningful, long-term results
They are also used clinically in some liver and immune support contexts, always under medical supervision
Structural modifications such as acylation or targeted amino acid substitutions extend their stability and half-life, enabling convenient daily or even weekly dosing
Glutathione is a natural component of breast milk
Nanotechnology applications show promise for improving bioavailability without compromising skin barrier function
